Director of SiriusPoint (NYSE: SPNT) receives 5,903-share grant, lifting holdings to 65,727

Rhea-AI Filing Summary

Masojada Bronislaw Edmund reported acquisition or exercise transactions in this Form 4 filing.

SiriusPoint Ltd director Bronislaw Edmund Masojada received an equity award of 5,903 Common Shares, valued at $23.29 per share. This was a grant, not an open-market purchase, and increased his direct holdings to 65,727 Common Shares. The position includes restricted shares that vest in full on May 30, 2027, subject to his continued service as a director.

Insights

Equity compensation analyst

Director received a routine share grant that modestly increases his equity stake.

The filing shows Bronislaw Edmund Masojada, a director of SiriusPoint Ltd, receiving 5,903 Common Shares as a grant or award at $23.29 per share. This is categorized as an acquisition via compensation, not an open-market purchase.

After the grant, his direct holdings rise to 65,727 Common Shares, including restricted shares scheduled to vest on May 30, 2027 if he continues serving as a director. With only one grant transaction and no sales, this appears to be standard board compensation rather than a directional trading signal.

The vesting condition ties part of his compensation to ongoing service over the period through 2027. Future company filings may provide additional detail on any subsequent grants or changes to his shareholdings.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Masojada Bronislaw Edmund

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	5,903	$23.29	$137K

Holdings After Transaction: Common Shares — 65,727 shares (Direct)

Footnotes (1)

1. Includes restricted shares that vest in full on May 30, 2027, subject to the Reporting Person's continued service as a director of the Company. Includes Restricted Shares.

Key Figures

Shares granted: 5,903 Common Shares Grant price: $23.29 per share Shares held after: 65,727 Common Shares +1 more

4 metrics

Shares granted 5,903 Common Shares Director equity grant on May 29, 2026

Grant price $23.29 per share Value used for the 5,903-share award

Shares held after 65,727 Common Shares Total direct holdings after the grant

Restricted share vesting date May 30, 2027 Restricted shares vest if director continues service

Key Terms

Grant, award, or other acquisition, Restricted Shares, Common Shares, Form 4

4 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Restricted Shares financial

"Includes restricted shares that vest in full on May 30, 2027"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Common Shares financial

"security_title: Common Shares"

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 05/29/2026 - 04:46 PM Accepted by SEC EDGAR 05/29/2026 - 04:46 PM Learn about SEC filing dates

FAQ

What did SiriusPoint Ltd (SPNT) director Bronislaw Masojada report in this Form 4?

He reported receiving 5,903 SiriusPoint Ltd Common Shares as a grant or award at $23.29 per share. This equity grant increased his direct holdings to 65,727 Common Shares, reflecting routine director compensation rather than an open-market purchase or sale.

Was the SiriusPoint Ltd (SPNT) Form 4 transaction a stock purchase or a grant?

The transaction was a grant or award of 5,903 Common Shares, not an open-market purchase. It is coded as an acquisition under transaction code “A,” indicating compensation-related equity rather than a discretionary buy or sell in the market.

How many SiriusPoint Ltd (SPNT) shares does Bronislaw Masojada hold after this Form 4 transaction?

Following the grant, Bronislaw Masojada directly holds 65,727 Common Shares of SiriusPoint Ltd. This total includes restricted shares that form part of his director compensation and are subject to vesting conditions over time.

What are the vesting terms of the restricted SiriusPoint Ltd (SPNT) shares in this filing?

The filing states that the holding includes restricted shares that vest in full on May 30, 2027. Vesting is contingent on Bronislaw Masojada’s continued service as a director of SiriusPoint Ltd through that date, aligning compensation with ongoing board service.

Does this SiriusPoint Ltd (SPNT) Form 4 show any share sales or dispositions by the director?

No, the Form 4 only reports an acquisition via a share grant of 5,903 Common Shares. There are no reported sales, tax-withholding dispositions, gifts, or other disposals in this filing; it reflects a single compensation-related award.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Masojada Bronislaw Edmund

(Last) (First) (Middle)

POINT BUILDING

3 WATERLOO LANE

(Street)

PEMBROKE HM08

(City) (State) (Zip)

BERMUDA

(Country)

2. Issuer Name and Ticker or Trading Symbol
SiriusPoint Ltd [ SPNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	05/29/2026		A		5,903(1)	A	$23.29	65,727(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes restricted shares that vest in full on May 30, 2027, subject to the Reporting Person's continued service as a director of the Company.

2. Includes Restricted Shares.

Remarks:

Exhibit 24-Power of Attorney

	/s/Jacquelyne Belcastro, Attorney-in-Fact for Bronislaw Edmund Masojada	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)